175 related articles for article (PubMed ID: 36543880)
1. Single-cell analysis reveals the chemotherapy-induced cellular reprogramming and novel therapeutic targets in relapsed/refractory acute myeloid leukemia.
Li K; Du Y; Cai Y; Liu W; Lv Y; Huang B; Zhang L; Wang Z; Liu P; Sun Q; Li N; Zhu M; Bosco B; Li L; Wu W; Wu L; Li J; Wang Q; Hong M; Qian S
Leukemia; 2023 Feb; 37(2):308-325. PubMed ID: 36543880
[TBL] [Abstract][Full Text] [Related]
2. Chemoresistance in acute myeloid leukemia: An alternative single-cell RNA sequencing approach.
Cheng PL; Hsiao TH; Chen CH; Hung MN; Jhan PP; Lee LW; Wu TS; Tsai JR; Teng CJ
Hematol Oncol; 2023 Aug; 41(3):499-509. PubMed ID: 36790759
[TBL] [Abstract][Full Text] [Related]
3. Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.
Williams MS; Basma NJ; Amaral FMR; Wiseman DH; Somervaille TCP
BMC Cancer; 2021 Oct; 21(1):1153. PubMed ID: 34711181
[TBL] [Abstract][Full Text] [Related]
4. LGALS1 acts as a pro-survival molecule in AML.
Ruvolo PP; Ma H; Ruvolo VR; Zhang X; Post SM; Andreeff M
Biochim Biophys Acta Mol Cell Res; 2020 Oct; 1867(10):118785. PubMed ID: 32590026
[TBL] [Abstract][Full Text] [Related]
5. Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.
Herrmann H; Blatt K; Shi J; Gleixner KV; Cerny-Reiterer S; Müllauer L; Vakoc CR; Sperr WR; Horny HP; Bradner JE; Zuber J; Valent P
Oncotarget; 2012 Dec; 3(12):1588-99. PubMed ID: 23249862
[TBL] [Abstract][Full Text] [Related]
6. A single-cell survey of cellular hierarchy in acute myeloid leukemia.
Wu J; Xiao Y; Sun J; Sun H; Chen H; Zhu Y; Fu H; Yu C; E W; Lai S; Ma L; Li J; Fei L; Jiang M; Wang J; Ye F; Wang R; Zhou Z; Zhang G; Zhang T; Ding Q; Wang Z; Hao S; Liu L; Zheng W; He J; Huang W; Wang Y; Xie J; Li T; Cheng T; Han X; Huang H; Guo G
J Hematol Oncol; 2020 Sep; 13(1):128. PubMed ID: 32977829
[TBL] [Abstract][Full Text] [Related]
7. Single-cell transcriptomics reveals multiple chemoresistant properties in leukemic stem and progenitor cells in pediatric AML.
Zhang Y; Jiang S; He F; Tian Y; Hu H; Gao L; Zhang L; Chen A; Hu Y; Fan L; Yang C; Zhou B; Liu D; Zhou Z; Su Y; Qin L; Wang Y; He H; Lu J; Xiao P; Hu S; Wang QF
Genome Biol; 2023 Aug; 24(1):199. PubMed ID: 37653425
[TBL] [Abstract][Full Text] [Related]
8. Loss-of-function mutations in BCOR contribute to chemotherapy resistance in acute myeloid leukemia.
Honda A; Koya J; Yoshimi A; Miyauchi M; Taoka K; Kataoka K; Arai S; Kurokawa M
Exp Hematol; 2021 Sep; 101-102():42-48.e11. PubMed ID: 34333045
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells.
Bista R; Lee DW; Pepper OB; Azorsa DO; Arceci RJ; Aleem E
J Exp Clin Cancer Res; 2017 Feb; 36(1):22. PubMed ID: 28143565
[TBL] [Abstract][Full Text] [Related]
10. METTL3 mediates chemoresistance by enhancing AML homing and engraftment via ITGA4.
Li M; Ye J; Xia Y; Li M; Li G; Hu X; Su X; Wang D; Zhao X; Lu F; Li J; Ma D; Sun T; Ji C
Leukemia; 2022 Nov; 36(11):2586-2595. PubMed ID: 36266324
[TBL] [Abstract][Full Text] [Related]
11. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, phase 2 trial.
DiNardo CD; Maiti A; Rausch CR; Pemmaraju N; Naqvi K; Daver NG; Kadia TM; Borthakur G; Ohanian M; Alvarado Y; Issa GC; Montalban-Bravo G; Short NJ; Yilmaz M; Bose P; Jabbour EJ; Takahashi K; Burger JA; Garcia-Manero G; Jain N; Kornblau SM; Thompson PA; Estrov Z; Masarova L; Sasaki K; Verstovsek S; Ferrajoli A; Weirda WG; Wang SA; Konoplev S; Chen Z; Pierce SA; Ning J; Qiao W; Ravandi F; Andreeff M; Welch JS; Kantarjian HM; Konopleva MY
Lancet Haematol; 2020 Oct; 7(10):e724-e736. PubMed ID: 32896301
[TBL] [Abstract][Full Text] [Related]
12. Unveiling novel insights in acute myeloid leukemia through single-cell RNA sequencing.
Zhou J; Chng WJ
Front Oncol; 2024; 14():1365330. PubMed ID: 38711849
[TBL] [Abstract][Full Text] [Related]
13. An Auristatin nanoconjugate targeting CXCR4+ leukemic cells blocks acute myeloid leukemia dissemination.
Pallarès V; Unzueta U; Falgàs A; Sánchez-García L; Serna N; Gallardo A; Morris GA; Alba-Castellón L; Álamo P; Sierra J; Villaverde A; Vázquez E; Casanova I; Mangues R
J Hematol Oncol; 2020 Apr; 13(1):36. PubMed ID: 32295630
[TBL] [Abstract][Full Text] [Related]
14. Effect of Compound Zhebei Granule () combined with chemotherapy on surface markers of leukemia stem cell in patients with acute myeloid leukemia.
Wang J; Lai ZL; Chen XY; Li DY; Zhang YY; Ma W; Chu YT; Shi FQ; Yang L; Hou L
Chin J Integr Med; 2016 Jun; 22(6):438-44. PubMed ID: 26666761
[TBL] [Abstract][Full Text] [Related]
15. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
[TBL] [Abstract][Full Text] [Related]
16. Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML.
Blatt K; Herrmann H; Hoermann G; Willmann M; Cerny-Reiterer S; Sadovnik I; Herndlhofer S; Streubel B; Rabitsch W; Sperr WR; Mayerhofer M; Rülicke T; Valent P
Clin Cancer Res; 2014 Jul; 20(13):3589-602. PubMed ID: 24799522
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
Naldini MM; Casirati G; Barcella M; Rancoita PMV; Cosentino A; Caserta C; Pavesi F; Zonari E; Desantis G; Gilioli D; Carrabba MG; Vago L; Bernardi M; Di Micco R; Di Serio C; Merelli I; Volpin M; Montini E; Ciceri F; Gentner B
Nat Commun; 2023 Mar; 14(1):1285. PubMed ID: 36890137
[TBL] [Abstract][Full Text] [Related]
18. The safety and efficacy of vosaroxin in patients with first relapsed or refractory acute myeloid leukemia - a critical review.
Short NJ; Ravandi F
Expert Rev Hematol; 2016 Jun; 9(6):529-34. PubMed ID: 27158854
[TBL] [Abstract][Full Text] [Related]
19. Aflibercept exerts antivascular effects and enhances levels of anthracycline chemotherapy in vivo in human acute myeloid leukemia models.
Lal D; Park JA; Demock K; Marinaro J; Perez AM; Lin MH; Tian L; Mashtare TJ; Murphy M; Prey J; Wetzler M; Fetterly GJ; Wang ES
Mol Cancer Ther; 2010 Oct; 9(10):2737-51. PubMed ID: 20924124
[TBL] [Abstract][Full Text] [Related]
20. MiR-15a-5p Confers Chemoresistance in Acute Myeloid Leukemia by Inhibiting Autophagy Induced by Daunorubicin.
Bollaert E; Claus M; Vandewalle V; Lenglez S; Essaghir A; Demoulin JB; Havelange V
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34068078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
